Laparoscopic right hemicolectomy: a comparison of natural orifice versus transabdominal specimen extraction
Background Conventional laparoscopic right hemicolectomy (LRH) involves making an abdominal incision to remove the specimen and perform the anastomosis. Totally laparoscopic right hemicolectomy with natural orifice specimen extraction (NOSE) may lead to better outcomes compared to LRH. Study design...
Gespeichert in:
Veröffentlicht in: | Surgical endoscopy 2014-10, Vol.28 (10), p.2871-2876 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
Conventional laparoscopic right hemicolectomy (LRH) involves making an abdominal incision to remove the specimen and perform the anastomosis. Totally laparoscopic right hemicolectomy with natural orifice specimen extraction (NOSE) may lead to better outcomes compared to LRH.
Study design
Forty consecutive female patients total were reviewed: 20 LRH and 20 NOSE. The two groups were matched for sex, age, race, American Society of Anesthesiologist score, benign and malignant disease, tumor stage, lymph node number, tumor size, specimen length, body mass index, previous abdominal surgeries, and comorbidities.
Results
The two groups were comparable for all categories. Follow-up was available on all patients (100 %). The mean follow-up was 38.93 months (range 15–63 months). There was no difference between postoperative pain score between the two groups on postoperative day (POD) 1, POD 2, and POD day 14 (
p
= 0.571), (
p
= 0.861), (
p
= 0.688), respectively. There was no difference in the postoperative in-hospital morphine equivalents (
p
= 0.963). The NOSE group had no postoperative hernia formation or wound infections compared to the LRH, however, the difference was not significant (
p
= 0.439) and (
p
= 0.267), respectively. There was no difference in postoperative ileus (
p
= 0.192), septic complications (
p
= 1.000), readmission rate (
p
= 0.394), time interval for postoperative chemotherapy (
p
= 0.645), SDS (
p
= 0.446) or QLI (
p
= 0.175). There was no difference in length of hospital stay with 5.3 days for the LRH group and 7.7 days for the NOSE group (
p
= 0.183). The NOSE group had statistically significant better cosmetic scores (
p
= 0.018).
Conclusion
NOSE is comparable LRH with regard to postoperative outcomes and quality of life. NOSE is safe and maintains strict oncologic standards. NOSE is associated with a better cosmetic outcome compared to LRH. |
---|---|
ISSN: | 0930-2794 1432-2218 |
DOI: | 10.1007/s00464-014-3540-8 |